Novo Nordisk A/S (NOVO:CA) Q2 2026 Earnings Call Transcript

Welcome to Novo Nordisk earnings call for the second quarter of 2026. My name is Michael Novod, and I'm the Head of Investor Relations at Novo Nordisk. With me today, I have CEO of Novo Nordisk, Mike ...
The Tech Edvocate

The Astonishing New Obesity Medications Arriving by 2026 That Could Change Everything

Spread the loveIf you’ve been following the world of weight loss and metabolic health, you know it’s a field buzzing with innovation. For years, the options for significant, sustainable weight loss ...

Acadia outlines $480M-$510M 2026 DAYBUE sales outlook as remlifanserin Phase II data nears Sep-Oct

DAYBUE guidance raised on STIX uptake, EU CHMP update, NUPLAZID outlook, and remlifanserin catalysts—read now.
Yahoo Finance

PFIZER INC CEDEAR 4 REP 1 ORD U (PFED.BA) Q1 FY2026 earnings call transcript

Earnings call Pfizer delivered Q1 2026 revenues of $14.5B (+2% operational YoY), exceeding expectations with 7% operational growth ex-COVID and strong cost control. Management reaffirmed full-year ...